(Q38661867)

5 September 2017

The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease (English)

1 reference

5 September 2017

0 references

1 reference

Jonathan R Kerr

1

1 reference

PubMed ID

26644521

5 September 2017

language of work or name

English

0 references

publication date

7 December 2015

1 reference

Journal of Clinical Pathology

5 September 2017

1 reference

5 September 2017

69

1 reference

5 September 2017

4

1 reference

5 September 2017

279-291

1 reference

Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini

5 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus diversity and DNA damage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

In vitro identification of a B19 parvovirus promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Erythrocyte P antigen: cellular receptor for B19 parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 transmission by heat-treated clotting factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 and blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 infection in blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Experimental parvoviral infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Characterization of a virus that causes transient aplastic crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Prolonged activation of virus-specific CD8+T cells after acute B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Short regions of sequence identity between the genomes of human and rodent parvoviruses and their respective hosts occur within host genes for the cytoskeleton, cell adhesion and Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Possible induction of systemic lupus erythematosus by human parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 infection: its relationship with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Does parvovirus B19 have a role in rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus infection in early rheumatoid and inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

The variable clinical picture of arthritis induced by human parvovirus B19. Report of seven adult cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Low frequency of recent parvovirus infection in a population-based cohort of patients with early inflammatory polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Rheumatoid arthritis after human parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 as a causative agent for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 transgenic mice become susceptible to polyarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Functional autoantibodies in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection as a cause of acute myositis in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Fulminant and accelerated presentation of dermatomyositis in two previously healthy young adult males: a potential role for endotheliotropic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection and myofasciitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

[Parvovirus B 19 infection during pregnancy]

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 associated adult Henoch Schönlein purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Successful Intravenous Immunoglobulin Therapy in 3 Cases of Parvovirus B19–Associated Chronic Fatigue Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Acute transverse myelitis associated with human parvovirus b19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Severe ataxia as a complication of human parvovirus B19 acute encephalitis in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Acute cerebellar ataxia with human parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

An unusual cause of cerebellar ataxia in an immunocompromised elderly patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Acute cerebellitis and concurrent encephalitis associated with parvovirus B19 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: a retrospective study of 26 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection complicated by peripheral facial palsy and parotitis with intraparotid lymphadenitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Isolated velopalatine paralysis associated with parvovirus B19 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection antedating Guillain-Barre' syndrome variant with prominent facial diplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Neurologic consequence of a parvovirus B19 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Neuralgic amyotrophy due to parvovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Neuralgic amyotrophy and polyarthritis caused by parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection revealed by prolonged dysesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Detection of antibodies in cardiac autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection mimicking acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Viral persistence in the myocardium is associated with progressive cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19-associated haemophagocytosis in Evans syndrome: aplastic crisis accompanied by severe thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

A case of pure red cell aplasia complicated by Evans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19-induced acute glomerulonephritis: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Association of parvovirus B19 infection and Hashimoto's thyroiditis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Myositis autoantibodies and clinical phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Autoantibodies in vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Neurological aspects of human parvovirus B19 infection: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

21 January 2018

Aquaporin-4 autoimmunity

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Identification of autoantibodies expressed in acquired aplastic anaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Antineutrophil cytoplasmic antibody associated vasculitis in one patient with severe aplastic anemia: description of the first case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Serous retinal detachment in a patient with aplastic anemia associated with parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Autoantibodies following parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

High frequency of parvovirus B19 in patients tested for rheumatoid factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Platelet Membrane Glycoprotein IIb/IIIa has Sequence Homologies with Human Virus Proteins and Synthetic Viral Peptides Inhibit Anti-GPIIb/IIIa Antibodies in Autoimmune Thrombocytopenic Purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Safety and immunogenicity of a candidate parvovirus B19 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

A viral phospholipase A2 is required for parvovirus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Parvovirus B19 infection and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

Immunogenetics of juvenile idiopathic arthritis: A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

HUMAN PARVOVIRUS ARTHROPATHY

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

HLA and acute arthritis following human parvovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203455

10.1136/JCLINPATH-2015-203455

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26644521